Amwell® Announces Results for First Quarter 2025
Amwell (NYSE: AMWL), a provider of SaaS-based technology-enabled healthcare platforms, has announced its financial results for the first quarter ending March 31, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amwell (NYSE: AMWL), a provider of SaaS-based technology-enabled healthcare platforms, has announced its financial results for the first quarter ending March 31, 2025. The company will host a conference call on May 1, 2025, at 5 p.m. ET to discuss these results. The earnings report can be accessed through Amwell's investor relations website, and the conference call will be available via live audio webcast, with a replay accessible afterward on the investor relations site.
Details
News Market Reaction – AMWL
The recorded move for AMWL in the trading session of this news was +19.71%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell’s investor relations website at investors.amwell.com to view the first quarter 2025 earnings report.
The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Contacts
Media:
Angela Vogen
Press@amwell.com
Investors:
Sue Dooley
sue.dooley@amwell.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.